ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Adicet Bio Inc

Adicet Bio Inc (ACET)

0.9919
0.0924
(10.27%)
마감 16 2월 6:00AM
0.9559
-0.036
(-3.63%)
시간외 거래: 9:48AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

ACET 뉴스

공식 뉴스 전용

ACET Discussion

게시물 보기
weedtrader420 weedtrader420 2 주 전
ACET☝️🤑☝️
👍️0
glenn1919 glenn1919 2 주 전
ACET......................................https://stockcharts.com/h-sc/ui?s=ACET&p=W&b=5&g=0&id=p86431144783
👍️0
Invest-in-America Invest-in-America 2 주 전
ACET: Fast Track this, & Fast Track that.
👍️0
Monksdream Monksdream 6 월 전
ACET under $2
👍️0
Monksdream Monksdream 7 월 전
ACET under $2
👍️0
Monksdream Monksdream 7 월 전
ACET under $2
👍️0
Monksdream Monksdream 8 월 전
ACET new 52 week low
👍️0
glenn1919 glenn1919 8 월 전
ACET..............................https://stockcharts.com/h-sc/ui?s=ACET&p=W&b=5&g=0&id=p86431144783
👍️0
JoseyWales88 JoseyWales88 8 월 전
HC Wainwright and Co reiterates BUY on ACET with a $10.00 price target


HC Wainwright and Co reiterates BUY on ACET with a $10.00 price target

👍️0
Mr. Zen Mr. Zen 8 월 전
Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)-- Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ADI-001 for the potential treatment of relapsed/refractory class III or class IV lupus nephritis.

“The FDA’s decision to grant ADI-001 Fast Track Designation for lupus nephritis underscores the urgent need for new therapies for this chronic disease,” said Chen Schor, President and Chief Executive Officer of Adicet Bio. “We plan to initiate our Phase 1 clinical study in lupus nephritis later this month. With clinical data for ADI-001 in non-Hodgkin’s lymphoma demonstrating CD19+ B-cell depletion that mirrors data by autologous alpha-beta CAR T in academic clinical studies in several autoimmune diseases, we believe we are well positioned to expand our autoimmune program to address additional indications beyond lupus nephritis. We look forward to providing a comprehensive update on our autoimmune program to investors in the near term.”

Fast Track Designation is a process designed to facilitate the development and expedite the review of drugs intended to treat serious conditions and fill an unmet medical need.

About Adicet Bio, Inc.

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. For more information, please visit our website at https://www.adicetbio.com.
👍️ 1
glenn1919 glenn1919 9 월 전
ACET....................................https://stockcharts.com/h-sc/ui?s=ACET&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 년 전
ACET new 52 week low
👍️0
Monksdream Monksdream 1 년 전
ACET new 52 week
👍️0
Monksdream Monksdream 1 년 전
ACET new 52 week low
👍️0
jondoeuk jondoeuk 1 년 전
Upcoming https://www.businesswire.com/news/home/20230927031162/en/Adicet-Bio-to-Present-Three-Scientific-Posters-Highlighting-its-Allogeneic-Gamma-Delta-T-Cell-Platform-and-Programs-at-the-Society-for-Immunotherapy-of-Cancer-SITC-38th-Annual-Meeting
👍️0
jondoeuk jondoeuk 2 년 전
https://twitter.com/JacobPlieth/status/1673585690716565504
👍️0
masterofdisaster masterofdisaster 3 년 전
No sell off...guess I bet wrong
👍️0
TheFinalCD TheFinalCD 3 년 전
Phase 1's usually suck wind, I lost $80K on another one,

BIG lesson learned


👍️0
masterofdisaster masterofdisaster 3 년 전
It was weird....I think the MMs drop this at open to begin the sell off today.
👍️0
TheFinalCD TheFinalCD 3 년 전
whats weird is the rally after the offering


this market is upside down

topsy turvey

👍️0
masterofdisaster masterofdisaster 3 년 전
Bought puts today anticipating an offering and there it is.
👍️0
TheFinalCD TheFinalCD 3 년 전
13.20 low start

ACET
👍️0
crudeoil24 crudeoil24 3 년 전
14.20 in AH. Nice day for the clinical FDA phase I trial results.
👍️0
TheFinalCD TheFinalCD 3 년 전
thanks for creating the board

I was too lazy, did I say lazy, I meant bizy

https://ih.advfn.com/stock-market/NASDAQ/adicet-bio-ACET/stock-news/86734727/adicet-posts-early-stage-data-for-off-the-shelf-ca
👍️0
crudeoil24 crudeoil24 3 년 전
Adicet Bio shares are trading higher after the company announced interim data from its dose escalation Phase 1 study evaluating the safety and tolerability of ADI-001.
👍️0
crudeoil24 crudeoil24 3 년 전
Adicet Bio Inc. is a biotechnology company that is focused on developing allogeneic gamma delta T cell therapies for cancer and other diseases. It is developing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs) and T cell receptor-like antibodies to enable selective tumor targeting, facilitate innate and adaptive anti-tumor immune response and improve persistence for durable activity in patients. Its pipeline includes ADI-001, ADI-002 and ADI-00x. ADI-001 is a gamma delta chimeric antigen receptor (CAR)-modified T cell therapy targeting CD20. ADI-002 is a gamma delta T cell containing a CAR that is specific for glypican 3 protein (GPC3). The Company is focused on developing ADI-00x for solid tumors and hematological indications.
👍️0